Form 4: Penumbra Inc. CFO Maggie Yuen Reports Stock Transactions
SEC Form 4 Filing
Chief Financial Officer of Penumbra Inc., Maggie Yuen, reports acquisition and disposal of common stock and restricted stock units.
Summary
- Maggie Yuen, CFO of Penumbra Inc., filed a Form 4 detailing changes in beneficial ownership.
- On February 14, 2025, Yuen was granted 780 restricted stock units (RSUs) under the company's equity incentive plan, vesting in equal installments over four years starting February 18, 2025.
- On February 18, 2025, Yuen was granted an additional 1,840 RSUs, also vesting in equal annual installments beginning February 15, 2026.
- Yuen disposed of 81 shares to cover tax withholding obligations related to RSU vesting at a price of $271.14 per share.
- Following these transactions, Yuen beneficially owns 17,243 shares of Penumbra Inc. common stock, a portion of which is subject to vesting.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the document simply reports stock transactions by a company insider, which is a routine occurrence.
Future Outlook
The reported transactions reflect ongoing equity compensation as part of Penumbra's incentive plan, with future vesting dates for the granted RSUs.
Industry Context
Form 4 filings are routine disclosures for company insiders and provide transparency into their transactions in the company's stock. This filing indicates ongoing equity compensation practices at Penumbra.
Comparison to Industry Standards
- Equity compensation is a standard practice in the medical device industry to align management's interests with those of shareholders.
- Companies like Medtronic, Boston Scientific, and Abbott also utilize RSUs and stock options as part of their compensation packages.
- The vesting schedules and amounts granted to Maggie Yuen appear consistent with typical executive compensation practices in similarly sized medical device companies.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders.
- They provide transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 02/14/2025 | Grant of 780 restricted stock units (RSUs) |
| 02/18/2025 | Initial vesting of 1/4 of the 780 RSUs granted on February 14, 2025 and grant of 1,840 RSUs |
| 02/18/2025 | Disposition of 81 shares for tax withholding |
| 02/15/2026 | Next vesting date for both RSU grants |
| 02/15/2027 | Vesting date for the 780 RSUs grant |
| 02/15/2028 | Final vesting date for the 780 RSUs grant |
| 02/19/2025 | Date of Form 4 filing |
Keywords
Form 4, Beneficial Ownership, Restricted Stock Units, RSUs, Stock Transactions, Penumbra Inc, Maggie Yuen, CFO, Equity Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.